RX Only: See important safety information about Suboxone
A Quick, Free Call
Your First Appointment
Suboxone, the Same Day
Enrollment Hours
6:00am - 7:00pm PST
The opioid crisis continues to impact Los Angeles, with use rates exceeding national averages. As of the most recent data, the prevalence of opioid use in Los Angeles stands at 4.7%, surpassing the national rate of 4.3%.
Access to treatment remains a challenge. Only 36% of individuals with opioid use disorder received any form of substance use treatment in 2021, and only 22% received medications specifically for opioid use disorder.
Policymakers, healthcare providers, and community organizations must work collaboratively to address this complex issue and improve outcomes for those affected by opioid use disorder.
Key Statistics on Opioid Use in Los Angeles
- Fentanyl-linked deaths increased from 109 in 2016 to 1,504 in 2021 (a 1,280% rise). In 2022, fentanyl-related deaths further increased to 1,910.
- Death rates from fentanyl have decreased among young adults (18-25) for two consecutive years.
- In 2023 alone, 728 homeless individuals died from fentanyl overdoses—a record high.
- Between 2006 and 2017, Los Angeles has experienced a substantial increase in opioid-related healthcare visits. Emergency room visits associated with opioids increased by 51%, while hospitalizations increased by 31%.
Opioid Overdose Statistics in Los Angeles
- Key areas within Los Angeles County have high opioid abuse and overdose rates. They include Antelope Valley (6.4 deaths per 100,000 residents), the Metro region (6 deaths per 100,000 residents), and West Los Angeles (5.7 deaths per 100,000 residents).
- Fentanyl is responsible for a significant increase in L.A. County opioid deaths in 2020.
- In Los Angeles’ District 1, the majority of homeless deaths in the previous year were attributed to opioids.
Demographic Data & Insights
- In 2019, Latinos in Los Angeles County had an age-adjusted opioid-related emergency department visit rate of 11.2 per 100,000, lower than the state average of 18.9.
- Of those receiving medications for opioid use disorder, 62% were 35 or older.
- Men accounted for 59% of individuals receiving medications for opioid use disorder.
- Adults aged 26-64 represent the highest number of overdose deaths.
- Between 2014 and 2023, over 2,100 unhoused individuals died from fentanyl-related causes.
Common Opioids & Prescribing Trends
- Fentanyl was involved in nearly 80% of all opioid overdose deaths in 2022.
- Prescription opioid use in Los Angeles and across the United States has changed significantly in recent years. While opioid prescribing has declined since 2010, the amount prescribed in 2015 remained three times higher than in 1999.
- High-volume prescribers wrote more prescriptions per patient (mean 6.7) compared to medium-volume (4.2) and low-volume (1.3) prescribers.
- Prescriptions from high-volume prescribers were for larger quantities of opioids (median 311 MME/prescription) compared to medium-volume (300 MME) and low-volume (189 MME) prescribers.
- Patients in the most rural counties (noncore) had an 87% higher chance of receiving an opioid prescription compared to those in large central metropolitan counties.
- Heroin continues to be the most commonly used illicit opioid. Synthetic opioids, particularly fentanyl, are increasingly prevalent
State Funds & Resource Allocation
- Los Angeles County has implemented various interventions and treatment programs to address the opioid crisis, aiming to prevent misuse, provide effective treatment, and reduce overdose deaths.
- The Los Angeles County Department of Health Services (LAC-DHS) has focused on reducing the number of opioid pills prescribed post-surgery.
- Officials are focused on culturally appropriate interventions, particularly for Latino communities. These targeted approaches aim to bridge the gap in care for vulnerable populations and communities most affected by the opioid crisis in Los Angeles.
- California has led the largest expansion of emergency department medication-assisted treatment programs in the country, significantly improving access to treatment for those with opioid use disorder.
Resources & Support Groups in Los Angeles
- Health Services Los Angeles County some text
- Offers referrals to treatment programs near Los Angeles
- Phone: 844-804-0055
- Website: https://sapccis.ph.lacounty.gov/sbat/
- Los Angeles Centers for Alcohol and Drug Abuse (L.A. CADA)some text
- Offers withdrawal management, inpatient treatment, outpatient care, and more
- Phone: 844-804-7727
- Website: https://www.lacada.com/
- Children’s Hospital Los Angeles some text
- Offers treatment for children and adolescents with drug problems, including education classes that can keep children from using drugs in the first place
- Phone: 323-361-2463
- Address: 3250 Wilshire Blvd., Suite 200, Los Angeles, CA 90010
Frequently Asked Questions
If you do not have insurance, the cost can vary based on the prescribed dose. Patients unable to afford buprenorphine/naloxone (Suboxone) (regardless of insurance coverage) can apply for cost-assistance. The company that makes Suboxone offers this type of program to help reduce out-of-pocket expenses. To learn more, go to: inSupport program.
You can also get discounted buprenorphine/naloxone (Suboxone) using pharmacy coupons or cash prizes. If you go to the GoodRx website (goodrx.com), you can enter in your zip code and find coupons and discounts at your pharmacy of choice. (On average, if you use GoodRx coupons/discounts, you can slash the typical price of generic Suboxone film from $395 to $118).
Before you are prescribed buprenorphine/naloxone (Suboxone), you will need to undergo an initial medical evaluation so that the doctor can ensure that it is an appropriate medication for you, though this does not require an in-person visit and can be done via telehealth (with video or telephone).
Once you have completed this assessment, the doctor will send a prescription to your preferred pharmacy. So, yes! You can find a licensed buprenorphine/naloxone (Suboxone) provider online and they can get you started on it via telehealth services without any in-person appointments.
- Buprenorphine/naloxone (Subxone) which is available in outpatient clinics (at your primary care doctor’s office or a psychiatrist’s office)
- Naloxone (Vivitrol) which is available in outpatient clinics (at your primary care doctor’s office or a psychiatrist’s office)
- Methadone, which is available only through methadone clinics
If you are interested in Buprenorphine/naloxone (Suboxone) offered entirely through telehealth services, visit bicyclehealth.com. To get help on finding other treatment options and levels of care (such as inpatient programs, intensive outpatient programs/IOPs, residential programs, and methadone clinics), call the SAMHSA helpline at:
1-800-662-HELP (4357).